Cargando…
Pancreas Transplantation from Donors after Circulatory Death: an Irrational Reluctance?
PURPOSE OF REVIEW: Beta-cell replacement is the best therapeutic option for patients with type 1 diabetes. Because of donor scarcity, more extended criteria donors are used for transplantation. Donation after circulatory death donors (DCD) are not commonly used for pancreas transplantation, because...
Autores principales: | Leemkuil, M., Leuvenink, H. G. D., Pol, R. A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6861341/ https://www.ncbi.nlm.nih.gov/pubmed/31741132 http://dx.doi.org/10.1007/s11892-019-1238-y |
Ejemplares similares
-
Simultaneous Pancreas-Kidney Transplantation Versus Living Donor Kidney Transplantation Alone: an Outcome-Driven Choice?
por: Venkatanarasimhamoorthy, Vishnu Swaroop, et al.
Publicado: (2018) -
Machine Perfusion and the Pancreas: Will It Increase the Donor Pool?
por: Hamaoui, Karim, et al.
Publicado: (2019) -
Pancreas-on-a-Chip Technology for Transplantation Applications
por: Abadpour, Shadab, et al.
Publicado: (2020) -
Organoids from the Human Fetal and Adult Pancreas
por: Balak, Jeetindra R. A., et al.
Publicado: (2019) -
Heterogeneity in the Beta-Cell Population: a Guided Search Into Its Significance in Pancreas and in Implants
por: Pipeleers, Daniel, et al.
Publicado: (2017)